Source content
FAA Guide for Aviation Medical Examiners · Version 10/28/2026 · page 694
AASI for Diabetes Mellitus - Type II
Medication Controlled (Not Insulin)
(Updated 01/28/2026)
AME Assisted Special Issuance (AASI) is a process that provides AMEs the ability to re-issue
an airman medical certificate under the provisions of an Authorization for Special Issuance of a
Medical Certificate (Authorization) to an applicant who has a medical condition that is
disqualifying under Title 14 of the Code of Federal Regulations (14 CFR) part 67.
An FAA physician provides the initial certification decision and grants the Authorization in
accordance with 14 CFR § 67.401. The Authorization letter is accompanied by attachments
that specify the information that treating physician(s) must provide for the re-issuance
determination. If this is a first-time application for an AASI for the above disease/condition,
and the applicant has all the requisite medical information necessary for a determination, the
AME must defer and submit all of the documentation to the AMCD or RFS for the initial
determination. The information can be submitted using the Diabetes or Hyperglycemia on
Medications Status Report.
AMEs may re-issue an airman medical certificate under the provisions of an Authorization,
provided that the applicant does not require insulin, remains on an acceptable oral
medication therapy according to the chart Acceptable Combinations of Diabetes
Medications, and if the applicant provides the following:
• An Authorization granted by the FAA AND either
• A Diabetes or Hyperglycemia on Medications Status Report OR
• A current status report from the physician treating the airman’s diabetes,
including:
o A statement attesting that the airman is maintaining his or her diabetic
diet;
o A statement regarding any diabetic symptomatology; including any
history of hypoglycemic events and any cardiovascular, renal, neurologic,
or ophthalmologic complications; and
o The results of a current HgA1c level performed within last 30 days.
The AME must defer to the AMCD or Region if, since the applicant’s last exam:
• The applicant has been placed on insulin;
• The HgA1c level is greater than 9.0 mg%
• The applicant has experienced:
o Severe Hypoglycemia event(s) - requiring assistance of another person
to actively administer carbohydrates, glucagon, or take other corrective
actions (plasma glucose concentrations may not be available) *
o Documented Symptomatic Hypoglycemia event(s) - typical symptoms of
hypoglycemia accompanied by a measured plasma glucose
concentration ≤70 mg/dL (≤3.9 mmol/L)*;
o Asymptomatic Hypoglycemia – no reported symptoms but a measured
plasma glucose concentration ≤54 mg/dL (≤3.0 mmol/L)
• The applicant has developed evidence of any of the following:
o Cardiovascular disease;
Shown as extracted from the FAA PDF, without paraphrasing. Tables and forms may lose their layout. Underlined references open the Guide location they name.
FAA Guide for Aviation Medical Examiners, Version 10/28/2026, page 694. AME Copilot is an independent reference tool, not affiliated with or endorsed by the FAA. The FAA AME Guide is the authoritative source.